PathAI AISight vs Proscia Concentriq
PathAI AISight and Proscia Concentriq both compete in pathology, but answer different questions. PathAI AISight is our pick for IMS + AI platform: Open IMS with AISight Dx + biopharma diagnostic services. Proscia Concentriq earns the pharma R&D labs slot: Used by 16/20 top pharma. $130M total funding. The right choice depends on whether your priority is ims + ai platform or pharma r&d labs.
- Pathology
- 02
- May 23, 2026
PathAI AISight
by PathAI · founded 2016
Open IMS platform with AISight Dx + biopharma diagnostic services.
- Enterprise.
- —
How PathAI AISight and Proscia Concentriq compare
Pricing, compliance, and integrations sourced from vendor documentation. Verified May 23, 2026.
| Spec | PathAI AISight | Proscia Concentriq |
|---|---|---|
| Pricing | Enterprise. | Enterprise. |
| Free tier | Yes | Yes |
| HIPAA | No / unverified | No / unverified |
| SOC 2 Type II | No / unverified | No / unverified |
| EHR integrations | Not specified | Not specified |
| Founded | 2016 | — |
| HQ | US | — |
| Best for | Best open IMS + AI platform | Best for pharma R&D labs |
Scroll horizontally to see both columns.
When to pick each one
Best open IMS + AI platform
Open IMS with AISight Dx + biopharma diagnostic services.
- Vendor-agnostic IMS appeals to mixed-vendor labs
- Strong biopharma R&D revenue
Best for pharma R&D labs
Used by 16/20 top pharma. $130M total funding.
- IMS platform + AI marketplace
- Strongest pharma R&D footprint
Open the full pathology comparison
Digital pathology workflows with FDA-cleared cancer detection (prostate, breast, colon), IHC scoring (HER2, Ki67), and AI-powered image management. Tempus, PathAI, Proscia dominate.
/best-ai-pathology